A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults
Phase 1
18–55
1 site in OH
What this study is about
This Phase 1 study is focused on people with healthy volunteers. The primary outcome being measured is Evaluate the safety and tolerability of single and multiple SRK-439 SC dose administration in healthy adult participants.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Evaluate the safety and tolerability of single and multiple SRK-439 SC dose administration in healthy adult participants
Secondary: Evaluate the PD of single and multiple SRK-439 SC dose administration in healthy adult participants, Evaluate the PK of single and multiple SRK-439 SC dose administration in healthy adult participants